Cardionyx Heart Science

Cardionyx Heart Science Overview

Cardionyx is developing an active implant to stimulate baroreceptors for Heart Failure (HF) patients, through a minimally invasive approach. Cardionyx stands at the forefront of medical innovation, poised to address the critical clinical needs of Heart Failure (HF) patients with reduced ejection fraction (HFrEF) through its groundbreaking approach. With a relentless focus on improving the lives of patients facing diminished life expectancy, frequent hospitalizations, and compromised quality of life (QOL), Cardionyx is developing a first-of-its-kind trans-vessel active implant designed to stimulate electricly baroreceptors, offering a potential game-changer in HF treatment. Unlike conventional therapies, which often leave a significant portion of patients ineligible or poorly managed, Cardionyx redefines the possibilities of intervention. At the core of this innovation lies an implant that leverages venous catheterization for implantation, ensuring a safer and quicker procedure which fits the clinical profile of this patient population. Another aspect that truly sets Cardionyx apart is its ability to provide personalized therapy coupled with real-time hemodynamic monitoring, allowing for the dynamic regulation of parasympathetic tone. This unique feature enables adjustable upregulation according to the patient's evolving hemodynamics, maximizing efficacy while minimizing adverse events and reducing the likelihood of baroreceptor desensitization.

Cumulative Funding Raised Over Time ($)

Latest News

Aug 24, 2021 · www.techtimes.com

growth-positive

Top 5 HealthTech Startups That Are Experts in Heart Failure

The article discusses the top 5 health tech startups that specialize in the innovative treatment of heart failure. The startups mentioned are Restore Medical, Metcela, Oracle Health, ESN Cleer, and Cardionyx. These companies have developed various technologies and therapies to improve the treatment of heart failure. The impact of the article on the companies is growth-positive, as it highlights their innovative solutions and potential to address the growing cases of heart failure. The key theme of the article is the improvement of heart failure treatment through technological advancements. The key issues discussed in the article are customers, as the startups aim to provide better solutions for heart failure patients. The date of the event described in the article is not specified. The confidence level of the answer is 8.

Customers

Funding

Team Members

3

Employees: 1-10

Web & Social Links

Locations

Tel Aviv, Israel

Holon, Israel

Photos & Videos

No files yet

Cardionyx Heart Science Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info